BIOCON391.00

Biocon Ltd.

· Pharma & Health
₹ CrorePeersSUNPHARMADRREDDYSYNGENEMANKINDGLENMARKLAURUSLABSALKEMLUPINMcap ₹63,381 Cr
Holding % of Total Shares
12 Months Ending
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
19/06/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
29/06/2026
Q1 FY27
30/06/2026
Promoter & Group60.6460.6460.6454.4554.4554.4554.4544.9144.6844.68
FII / FPI5.935.665.667.006.046.617.397.528.168.14
DII14.4415.3715.7221.4522.8222.1021.7124.0723.3723.38
Mutual Funds7.978.588.7713.8215.2414.1313.7516.5315.4915.47
Latest: 2026-06-30 · 66 quarters of history · click a row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.